Probiotics in the critically ill: Handle with care!

Pediatric Critical Care Medicine

Volumn 8, Issue 5, 2007, Pages 499-501

  Singhi, Sunit ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Children; Intensive care; Nosocomial infections; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; PROBIOTIC AGENT;

APOPTOSIS; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRITICALLY ILL PATIENT; CYTOKINE RELEASE; DRUG MECHANISM; ECZEMA; EDITORIAL; GASTROINTESTINAL TRACT; HUMAN; INTENSIVE CARE UNIT; LEUKOCYTE ACTIVATION; META ANALYSIS; MICROORGANISM; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW;

CRITICAL ILLNESS; CROSS INFECTION; HUMANS; LACTOBACILLUS RHAMNOSUS; PROBIOTICS;

EID: 34548661682     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000282165.04260.59     Document Type: Editorial

References (22)

1. Alverdy JC, Laughlin RS, Wu L: Influence of the critically ill state on host-pathogen interactions within the intestine: Gut-derived sepsis redefined. Crit Care Med 2003; 31: 598-607
2. Leveau P, Wang X, Soltesz V, et al: Alterations in intestinal motility and microflora in experimental acute pancreatitis. Int J Pancreatol 1996; 20:119-125
3. Wang X, Andersson R, Soltesz V, et al: Gut origin sepsis, macrophage function, and oxygen extraction associated with acute pancreatitis in the rat. World J Surg 1996; 20: 299-308
4. Doron S, Snydman DR, Gorbach SL: Lactobacillus GG: Bacteriology and clinical applications. Gastroenterol Clin North Am 2005; 34:483-498
5. Mohan R, Koebnick C, Schildt J, et al: Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: A double-blind, placebo-controlled, randomized study. J Clin Microbiol 2006; 44: 4025-4031
6. Gluck U, Gebbers JO: Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 2003; 77:517-520
7. Jain PK, McNaught CE, Anderson AD, et al: Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus, and oligofructose on gut barrier function and sepsis in critically ill patients: A randomised controlled trial. Clin Nutr 2004; 23:467-475
8. Bengmark S: Bioecologic control of the gastrointestinal tract: The role of flora and supplemented probiotics and synbiotics. Gastroenterol Clin North Am 2005; 34: 413-436
9. Manzoni P, Mostert M, Leonessa ML, et al: Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: A randomized study. Clin Infect Dis 2006; 42:1735-1742
10. Honeycutt TCB, El Khashab M, Wardrop RM III, et al: Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: A randomized placebo-controlled trial. Pediatr Crit Care Med 2007; 8:452-458
11. Dani C, Biadaioli R, Bertini G, et al: Probiotics feeding in prevention of urinary tract infection, bacterial sepsis, and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82:103-108
12. McNaught CE, Woodcock NP, Anderson AD: A prospective randomized trial of probiotics in critically ill patients. Clin Nutr 2005; 24: 211-219
13. Alberda C, Gramlich L, Meddings J, et al: Effects of probiotic therapy in critically ill patients: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2007; 85: 816-823
14. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, et al: Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: Early results of a randomized controlled trial. World J Surg 2006; 30: 1848-1855
15. Munoz P, Bouza E, Cuenca-Estrella M, et al: Saccharomyces cerevisiae fungemia: An emerging infectious disease. Clin Infect Dis 2005; 40:1625-1634
16. Srinivasan R, Meyer R, Padmanabhan R, et al: Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. J Pediatr Gastroenterol Nutr 2006; 42: 171-173
17. Kukkonen K, Savilahti E, Haahtela T, et al: Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:192-198
18. Taylor AL, Dunstan JA, Prescott SL: Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J Allergy Clin Immunol 2007; 119:184-191
19. Brouwer ML, Wolt-Plompen SA, Dubois AE, et al: No effects of probiotics on atopic dermatitis in infancy: A randomized placebo-controlled trial. Clin Exp Allergy 2006; 36: 899-906
20. Szajewska H, Ruszczynski M, Radzikowski A: Probiotics in the prevention of antibiotic-associated diarrhea in children: A metaanalysis of randomized controlled trials. J Pediatr 2006; 149:367-372
21. Johnston BC, Supina AL, Vohra S: Probiotics for pediatric antibiotic-associated diarrhea: A meta-analysis of randomized placebo-controlled trials [published erratum appears in CMAJ 2006; 175:777]. CMAJ 2006; 175: 377-383
22. Boyle RJ, Robins-Browne RM, Tang ML: Probiotic use in clinical practice: What are the risks? Am J Clin Nutr 2006; 83: 1256-1264